J
Jutro medical
Primary healthcare startup that offers next-level patient satisfaction through a unique online and offline, hybrid model
About Jutro medical
Jutro Medical is a Warsaw AI-first primary care operator founded in 2020 by CEO Adam Janczewski that combines telemedicine with proprietary clinics on a shared electronic health record (EHR), clinic operations stack and AI agents for intake and documentation. Patients can consult virtually for prescriptions, referrals, labs and medical leave, then see the same clinician in person when needed; AI use is optional and clinicians retain clinical decisions. The company acquires GP practices and migrates them onto one platform, reporting about 120,000 patients, roughly 20 targeted acquisitions a year, and strong visit NPS. In December 2025 Jutro raised a €24 million Series A extension led by Warsaw Equity Group with Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC and Inovo VC, plus a debt component from mBank and Orbit Capital, bringing total Series A to €36 million to fund further Polish clinic rollups, European expansion and AI agent development. Sources: EU-Startups / Tech.eu 16 Dec 2025.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Warsaw, Poland
- Employees
- 122
- Open positions
- 42
- Dealroom signal
- 88.6/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Smoking, Critical medical care, Mental Health, Telemedicine, Tech for Patients, Addiction, Hard Tech
- Technology
- Artificial Intelligence, Mobile app
- Business model
- SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2025 | $26M | $106M | Fluent Ventures · naturalX Health Ventures · Warsaw Equity Group · Vinci | ↗ |
| DEBT✓Debt | Mar 2025 | $2.6M | — | mBank · ORBIT Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Jutro medical is 94K monthly website visits, up 108.9% over the last three months. Jutro medical's team grew 9.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed9 investors entered at this stage
Kogito Ventures
Marcin Tchórzewski
Rheingau Founders
Inovo.vc
Market One Capital- MZMaciej Zużałek
- MNMaciej Noga
- CGChris Guzowski
- ABAniołowie Biznesu
Series A6 investors entered at this stage
KAYA VC
RIO ASI
Warsaw Equity Group
Fluent Ventures
naturalX Health Ventures
Vinci
Series B and later2 investors entered at this stage
mBank
ORBIT Capital
Other known investors2 additional known investors
Google for Startups Accelerator
PFR Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jutro medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jutro medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.